Exercise Training in Patients With Rheumatoid Arthritis and Cryotherapy
NCT ID: NCT02855801
Last Updated: 2017-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
8 participants
INTERVENTIONAL
2013-06-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aerobic Exercise Program Followed by Cold Water Immersion: Effects on Arthritis Patients Arterial Stiffness
NCT03911830
A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid Arthritis
NCT01553305
Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
NCT01228812
Cryotherapy and Doppler in Inflammatory Rheumatic Diseases
NCT02573298
Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension
NCT00491309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
constant exercise without cryotherapy
constant exercise without cryotherapy
constant exercise
constant exercise with cryotherapy
constant exercise with cryotherapy
constant exercise
cryotherapy
intermittent exercise, no cryotherapy
intermittent exercise without cryotherapy
intermittent exercise
intermittent exercise and cryotherapy
intermittent exercise with cryotherapy
cryotherapy
intermittent exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
constant exercise
cryotherapy
intermittent exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signature of informed consent for participation
* Affiliation to a social security scheme or French beneficiary of such a regime.
* confirmed rheumatoid arthritis and monitoring by the rheumatology department of the University Hospital of Besancon.
* If there is a corticosteroid therapy, it must be stable for at least 1 month and less than or equal to 10 mg of prednisone equivalent per day
* Clinical and biological activity will be moderate (ie not in remission and not severe based on Disease Activity Score 28 joints - DAS 28 - to be between 2 and 6
* Patients could be treated with DMARDs (Disease-Modifying Drugs).
Exclusion Criteria
* Patients whose body mass index (BMI) greater than 30,
* Pathology incompatible with the completion of a cycle ergometer exercise (heart, vascular, respiratory, orthopedic ...)
* Change in DAS28 greater than 1.2 in the previous 3 months Inclusion
* A patient with a DAS28 \> 6
* about the cold: Raynaud's syndrome, cold known allergy, sickle cell anemia, cryoglobulinemia, uncontrolled hypertension
* Patient unable to follow protocol because of cognitive, psychiatric or language difficulties.
* Inability to follow protocol for causes related to health problems (unrelated Rheumatoid Arthritis) or socio-professional.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clement Pati, MD
Role: PRINCIPAL_INVESTIGATOR
CHRU Besancon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Régional Universitaire
Besançon, Franche-Comté, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/2012/139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.